tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Genix Pharmaceuticals Secures $100,000 in Private Placement

Story Highlights
Genix Pharmaceuticals Secures $100,000 in Private Placement

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Genix Pharmaceuticals ( (TSE:GENX) ) has shared an update.

Genix Pharmaceuticals Corporation has successfully closed a non-brokered private placement, raising $100,000 through the issuance of 2,000,000 units at $0.10 per unit. The funds will be used for general working capital and potential new product funding. The placement involved participation from company insiders, including the President and CEO, and is considered a related party transaction. The securities are subject to a hold period and require regulatory approval, but are not registered under the U.S. Securities Act.

More about Genix Pharmaceuticals

Genix Pharmaceuticals Corporation is a Canadian company specializing in ophthalmic drugs. It focuses on the research, development, manufacture, licensing, and sales of innovative prescription and over-the-counter ophthalmological products, aiming to meet the global demand for advanced eye-care solutions.

Average Trading Volume: 21,946

Technical Sentiment Signal: Sell

Current Market Cap: C$1.78M

See more insights into GENX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1